A two-pronged approach to generating novel models of photoreceptor degeneration for regenerative cell therapy

Information

  • Research Project
  • 10329873
  • ApplicationId
    10329873
  • Core Project Number
    U24EY033272
  • Full Project Number
    1U24EY033272-01
  • Serial Number
    033272
  • FOA Number
    RFA-EY-20-001
  • Sub Project Id
  • Project Start Date
    9/30/2021 - 2 years ago
  • Project End Date
    7/31/2026 - 2 years from now
  • Program Officer Name
    GREENWELL, THOMAS
  • Budget Start Date
    9/30/2021 - 2 years ago
  • Budget End Date
    7/31/2022 - a year ago
  • Fiscal Year
    2021
  • Support Year
    01
  • Suffix
  • Award Notice Date
    9/15/2021 - 2 years ago

A two-pronged approach to generating novel models of photoreceptor degeneration for regenerative cell therapy

PROJECT SUMMARY Inherited retinal diseases (IRD), such as retinitis pigmentosa (RP), Leber congenital amaurosis (LCA), are a common cause of visual impairment worldwide. Recent studies show that cell replacement therapy is a promising therapeutic option for IRD patients with severe retinal degeneration that destroys photoreceptors. We and others recently reported long-term survival and integration of human embryonic stem cells (hESCs) or human induced pluripotent stem cells (hiPSCs) derived retinas in a novel laser-induced photoreceptor degeneration model. While the laser ablation model can be generated rapidly as an acute degeneration model, it does not have the progressive pathophysiological nature (e.g., disease time course, retinal remodeling, etc.) of IRD. To address this issue, we developed a highly efficient genome-editing technology, Platinum Talen, which leads to gene disruption in multiple organisms with high efficacy and specificity. By applying Platinum Talen to this novel model, we achieved one-step generation of biallelic gene modifications with high efficiency (40-50%) in preliminary studies. Since substantial information regarding the survival and integration of transplanted photoreceptor cells or retinal sheets have been obtained in laser injury models, we propose a two-pronged strategy to generating novel translation-enabling models to evaluate survival and integration of regenerated photoreceptors in the visual system: 1) to use laser-induced photoreceptor degeneration model; 2) one-step generation of biallelic mutants by Platinum Talen. We will then systematically compare the survival and integration of regenerated photoreceptors in the two model systems. Aim 1 will generate novel models of photoreceptor degeneration by laser ablation and Platinum Talen. Aim 2 will perform comprehensive ophthalmic phenotyping of laser-induced and Talen-edited models of photoreceptor degeneration. Aim 3 will evaluate survival and integration of human induced pluripotent stem cell (hiPSC)-derived retina sheets in the two models of photoreceptor degeneration.

IC Name
NATIONAL EYE INSTITUTE
  • Activity
    U24
  • Administering IC
    EY
  • Application Type
    1
  • Direct Cost Amount
    885824
  • Indirect Cost Amount
    151723
  • Total Cost
    1037547
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    867
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NEI:1037547\
  • Funding Mechanism
    OTHER RESEARCH-RELATED
  • Study Section
    ZEY1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    BAYLOR COLLEGE OF MEDICINE
  • Organization Department
    OPHTHALMOLOGY
  • Organization DUNS
    051113330
  • Organization City
    HOUSTON
  • Organization State
    TX
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    770303411
  • Organization District
    UNITED STATES